{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:04:44Z","timestamp":1790258684188,"version":"4.1.0"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["5R01NS126089"],"award-info":[{"award-number":["5R01NS126089"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1R01DA054535"],"award-info":[{"award-number":["1R01DA054535"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neubiorev.2026.106932","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T19:21:44Z","timestamp":1788031304000},"page":"106932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Does HIV-1 infection drive Alzheimer\u2019s disease pathobiology?"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0752-5029","authenticated-orcid":false,"given":"Elizabeth O.","family":"Etafo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6038-2416","authenticated-orcid":false,"given":"Debashis","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5687-0705","authenticated-orcid":false,"given":"Shaurav","family":"Bhattarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard E.","family":"Gendelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9064-1084","authenticated-orcid":false,"given":"Santhi","family":"Gorantla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neubiorev.2026.106932_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s13365-016-0505-9","article-title":"Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda","volume":"23","author":"Abassi","year":"2017","journal-title":"J. Neurovirol."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106932_bib2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11481-009-9152-8","article-title":"Increased accumulation of intraneuronal amyloid beta in HIV-infected patients","volume":"4","author":"Achim","year":"2009","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.106932_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101153","article-title":"Transposable elements in brain health and disease","volume":"64","author":"Ahmadi","year":"2020","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s13365-018-0682-9","article-title":"White matter damage, neuroinflammation, and neuronal integrity in HAND","volume":"25","author":"Alakkas","year":"2019","journal-title":"J. Neurovirol."},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106932_bib5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00401-006-0037-0","article-title":"Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy","volume":"111","author":"Anthony","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib6","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1093\/infdis\/jiac388","article-title":"Cognitive health in persons with human immunodeficiency virus: the impact of early treatment, comorbidities, and aging","volume":"227","author":"Aung","year":"2023","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12981-023-00511-5","article-title":"Role of microglia in HIV-1 infection","volume":"20","author":"Bai","year":"2023","journal-title":"AIDS Res. Ther."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106932_bib8","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1074\/jbc.M111.262543","article-title":"Up-regulation of the neuronal nicotinic receptor alpha7 by HIV glycoprotein 120: potential implications for HIV-associated neurocognitive disorder","volume":"287","author":"Ballester","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106932_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12040608","article-title":"The humanized mouse model: what added value does it offer for HIV research?","volume":"12","author":"Baroncini","year":"2023","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13024-021-00500-0","article-title":"CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice","volume":"16","author":"Bhargavan","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2026.106932_bib11","doi-asserted-by":"crossref","DOI":"10.1515\/nipt-2024-0018","article-title":"HIV-1 infection facilitates Alzheimer\u2019s disease pathology in humanized APP knock-in immunodeficient mice","author":"Bhattarai","year":"2025","journal-title":"NeuroImmune Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106932_bib12","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jpsychires.2006.02.001","article-title":"Cognitive deterioration in Alzheimer's disease is accompanied by increase of plasma neopterin","volume":"41","author":"Blasko","year":"2007","journal-title":"J. Psychiatr. Res."},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106932_bib13","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/QAD.0000000000002597","article-title":"HIV and risk of dementia in older veterans","volume":"34","author":"Bobrow","year":"2020","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106932_bib14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1750-3639.2011.00550.x","article-title":"Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation","volume":"22","author":"Bonneh-Barkay","year":"2012","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/07853890.2020.1814962","article-title":"Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis","volume":"53","author":"Borrajo","year":"2021","journal-title":"Ann. Med."},{"key":"10.1016\/j.neubiorev.2026.106932_bib16","doi-asserted-by":"crossref","DOI":"10.1515\/nipt-2025-0019","article-title":"Analyses of astrocyte-neuron lactate shuttle transporter levels in brain tissues from people with HIV-associated neurocognitive impairment and Alzheimer's disease","author":"Boustani","year":"2026","journal-title":"NeuroImmune Pharm. Ther."},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106932_bib17","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1212\/01.wnl.0000183293.95787.b7","article-title":"CSF amyloid \u03b242 and tau levels correlate with AIDS dementia complex","volume":"65","author":"Brew","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2026.106932_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1326-9-40","article-title":"The role of tau protein in HIV-associated neurocognitive disorders","volume":"9","author":"Brown","year":"2014","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106932_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095500","article-title":"Efavirenz promotes \u03b2-secretase expression and increased A\u03b21-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND)","volume":"9","author":"Brown","year":"2014","journal-title":"PLoS. ONE"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/v15010228","article-title":"Use of Hu-PBL mice to study pathogenesis of human-restricted viruses","volume":"15","author":"Brunetti","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.neubiorev.2026.106932_bib21","article-title":"The role of oxidative stress in HIV-associated neurocognitive disorders","volume":"13","author":"Buckley","year":"2021","journal-title":"Brain Behav. & Immun. - Health"},{"key":"10.1016\/j.neubiorev.2026.106932_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1570692","article-title":"Neuroinflammation associated with proviral DNA persists in the brain of virally suppressed people with HIV","volume":"16","author":"Byrnes","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106932_bib23","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s10571-018-0603-8","article-title":"Nicotinic acetylcholine receptors in HIV: possible roles during HAND and inflammation","volume":"38","author":"Cap\u00f3-V\u00e9lez","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib24","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41598-018-20271-x","article-title":"The alpha7-nicotinic receptor contributes to gp120-induced neurotoxicity: implications in HIV-associated neurocognitive disorders","volume":"8","author":"Capo-Velez","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106932_bib25","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1007\/s10787-026-02274-7","article-title":"Decoding neuroinflammation: the critical role of NLRP3 inflammasome in Alzheimer's disease","volume":"34","author":"Chaudhary","year":"2026","journal-title":"Inflammopharmacology"},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106932_bib26","article-title":"Nucleoside reverse transcriptase inhibitor exposure is associated with lower Alzheimer's disease risk: a retrospective Cohort proof-of-concept study","volume":"17","author":"Chow","year":"2024","journal-title":"Pharm. (Basel)"},{"issue":"23","key":"10.1016\/j.neubiorev.2026.106932_bib27","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181c5b445","article-title":"CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease","volume":"73","author":"Clifford","year":"2009","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106932_bib28","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/archneur.64.12.1771","article-title":"Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease","volume":"64","author":"Counts","year":"2007","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106932_bib29","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1194\/jlr.M023119","article-title":"HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux","volume":"53","author":"Cui","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neubiorev.2026.106932_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12883-015-0298-0","article-title":"APOE epsilon4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study","volume":"15","author":"Cysique","year":"2015","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12977-021-00557-1","article-title":"Humanized mice for infectious and neurodegenerative disorders","volume":"18","author":"Dash","year":"2021","journal-title":"Retrovirology"},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106932_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1014446","article-title":"The brain as an HIV reservoir: recent findings using autopsy tissues from people with HIV","volume":"22","author":"Dave","year":"2026","journal-title":"PLoS. Pathog."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106932_bib33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/QAI.0000000000001666","article-title":"Neprilysin in the cerebrospinal fluid and serum of patients infected With HIV1-subtypes C and B","volume":"78","author":"de Almeida","year":"2018","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"21","key":"10.1016\/j.neubiorev.2026.106932_bib34","doi-asserted-by":"crossref","first-page":"10750","DOI":"10.1093\/cercor\/bhad313","article-title":"Microglia complement signaling promotes neuronal elimination and normal brain functional connectivity","volume":"33","author":"Deivasigamani","year":"2023","journal-title":"Cereb. Cortex"},{"issue":"38","key":"10.1016\/j.neubiorev.2026.106932_bib35","doi-asserted-by":"crossref","first-page":"13377","DOI":"10.1074\/jbc.RA120.014642","article-title":"Modification of lipid rafts by extracellular vesicles carrying HIV-1 protein Nef induces redistribution of amyloid precursor protein and Tau, causing neuronal dysfunction","volume":"295","author":"Ditiatkovski","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106932_bib36","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s13365-022-01081-4","article-title":"Higher cerebrospinal fluid biomarkers of neuronal injury in HIV-associated neurocognitive impairment","volume":"28","author":"Ellis","year":"2022","journal-title":"J. Neurovirol"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11481-024-10126-w","article-title":"Alzheimer-type cerebral amyloidosis in the context of HIV infection: implications for a proposed new treatment approach","volume":"19","author":"Ellis","year":"2024","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106932_bib38","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/QAD.0000000000002506","article-title":"Beta amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy","volume":"34","author":"Fields","year":"2020","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106932_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/COH.0000000000000958","article-title":"Single cell analyses of the HIV reservoir in the CNS and CSF: recent insights and implications","volume":"20","author":"Filippidis","year":"2025","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106932_bib40","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1017\/S1355617724000201","article-title":"Neuropsychological tests associated with symptomatic HIV-associated neurocognitive disorder (HAND) in a cohort of older adults in Tanzania","volume":"30","author":"Fotheringham","year":"2024","journal-title":"J. Int. Neuropsychol. Soc."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2377-9-63","article-title":"Amyloid and tau cerebrospinal fluid biomarkers in HIV infection","volume":"9","author":"Gissl\u00e9n","year":"2009","journal-title":"BMC Neurol."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106932_bib42","first-page":"260","article-title":"HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide","volume":"1","author":"Giunta","year":"2008","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106932_bib43","first-page":"433","article-title":"HIV-1 Tat contributes to Alzheimer's disease-like pathology in PSAPP mice","volume":"2","author":"Giunta","year":"2009","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106932_bib44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tins.2011.12.006","article-title":"Rodent models for HIV-associated neurocognitive disorders","volume":"35","author":"Gorantla","year":"2012","journal-title":"Trends Neurosci."},{"issue":"34","key":"10.1016\/j.neubiorev.2026.106932_bib45","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2503988122","article-title":"Negative interplay between HIV-1 Gag and amyloid precursor protein centers around competition for VPS4A and TSG101","volume":"122","author":"Gu","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib46","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1038\/s41467-023-40000-x","article-title":"HIV-1 promotes ubiquitination of the amyloidogenic C-terminal fragment of APP to support viral replication","volume":"14","author":"Gu","year":"2023","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106932_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/v15091829","article-title":"CSF inflammation markers associated with asymptomatic viral escape in cerebrospinal fluid of HIV-positive individuals on antiretroviral therapy","volume":"15","author":"Guha","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.neubiorev.2026.106932_bib48","doi-asserted-by":"crossref","DOI":"10.1007\/s10787-026-02324-0","article-title":"Regulation of NLRP3 inflammasome signaling in Alzheimer's disease: emerging neuroprotective role of phytochemicals","author":"Gupta","year":"2026","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neubiorev.2026.106932_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-6405-7-15","article-title":"Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection","volume":"7","author":"Hagberg","year":"2010","journal-title":"AIDS Res. Ther."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106932_bib50","doi-asserted-by":"crossref","DOI":"10.1007\/s13365-026-01309-7","article-title":"A cross-cohort comparison of the prevalence and clinical significance of Alzheimer's disease biomarkers in people with versus without HIV","volume":"32","author":"Ham","year":"2026","journal-title":"J. Neurovirol"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib51","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-026-03876-2","article-title":"Convergence of neuroinflammation across major neurotropic viral exposomes in AD and ADRD","volume":"23","author":"Harmouch","year":"2026","journal-title":"J. Neuroinflamm."},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106932_bib52","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1093\/infdis\/jiz030","article-title":"Very early initiation of antiretroviral therapy during acute HIV infection is associated with normalized levels of immune activation markers in cerebrospinal fluid but not in plasma","volume":"220","author":"Hellmuth","year":"2019","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib53","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12974-019-1404-9","article-title":"Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection","volume":"16","author":"Hermansson","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neubiorev.2026.106932_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1425525","article-title":"S100B actions on glial and neuronal cells in the developing brain: an overview","volume":"18","author":"Hernandez-Ortega","year":"2024","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11481-019-09862-1","article-title":"Antiretroviral drugs promote amyloidogenesis by de-acidifying endolysosomes","volume":"16","author":"Hui","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106932_bib56","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00002093-200010000-00007","article-title":"Elevated plasma neopterin levels in Alzheimer disease","volume":"14","author":"Hull","year":"2000","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106932_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012446","article-title":"HIV transcription persists in the brain of virally suppressed people with HIV","volume":"20","author":"Jamal Eddine","year":"2024","journal-title":"PLoS. Pathog."},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106932_bib58","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200286","article-title":"Alzheimer's disease-like perturbations in HIV-mediated neuronal dysfunctions: understanding mechanisms and developing therapeutic strategies","volume":"10","author":"Jha","year":"2020","journal-title":"Open. Biol."},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106932_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077972","article-title":"HIV-1 tat interacts with and regulates the localization and processing of amyloid precursor protein","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS. ONE"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106932_bib60","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/QAD.0000000000002806","article-title":"Comparison of dementia risk after age 50 between individuals with and without HIV infection","volume":"35","author":"Lam","year":"2021","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf791","article-title":"Impact of delayed HIV diagnosis and treatment on dementia risk in later life","volume":"13","author":"Lam","year":"2026","journal-title":"Open. Forum Infect. Dis."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106932_bib62","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/QAD.0000000000004421","article-title":"Dementia incidence and prevalence in older adults with HIV: a 23-year retrospective cohort study","volume":"40","author":"Lam","year":"2026","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106932_bib63","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11481-011-9304-5","article-title":"The Effect of HIV protease inhibitors on amyloid-\u03b2 peptide degradation and synthesis in human cells and Alzheimer\u2019s disease animal model","volume":"7","author":"Lan","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106932_bib64","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/18756190MTA44NjEs3","article-title":"Targeting S100B protein as a surrogate biomarker and its role in various neurological disorders","volume":"19","author":"Langeh","year":"2021","journal-title":"Curr. Neuropharmacol."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106932_bib65","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s12272-021-01340-8","article-title":"Amyloidogenic, neuroinflammatory and memory dysfunction effects of HIV-1 gp120","volume":"44","author":"Lee","year":"2021","journal-title":"Arch. Pharm. Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106932_bib66","first-page":"45","article-title":"Neurologic complications of HIV disease and their treatment","volume":"18","author":"Letendre","year":"2010","journal-title":"Top. HIV Med. a Publ. Int. AIDS Soc. USA"},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106932_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/v14061268","article-title":"Intraneuronal beta-amyloid accumulation: aging HIV-1 human and HIV-1 transgenic rat brain","volume":"14","author":"Li","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.neubiorev.2026.106932_bib68","doi-asserted-by":"crossref","DOI":"10.1177\/13872877261469862","article-title":"Microglial immunometabolic reprogramming in Alzheimer's disease: from mitochondrial dysfunction and redox imbalance to NLRP3 inflammasome-driven neuroinflammation","author":"Li","year":"2026","journal-title":"J. Alzheimers Dis."},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106932_bib69","first-page":"1489","article-title":"Systemic HIV-1 infection produces a unique glial footprint in humanized mouse brains","volume":"10","author":"Li","year":"2017","journal-title":"Dis. Model. Mech."},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106932_bib70","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/QAD.0000000000004204","article-title":"Senescence-related cytokine levels are associated with HIV-1 serostatus and persistence","volume":"39","author":"Li","year":"2025","journal-title":"AIDS"},{"issue":"s1","key":"10.1016\/j.neubiorev.2026.106932_bib71","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1017\/S135561772300139X","article-title":"57 CSF markers of AD-related pathology relate to aMCI among People with HIV","volume":"29","author":"Lobo","year":"2023","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.neubiorev.2026.106932_bib72","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.npep.2018.12.003","article-title":"Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease","volume":"73","author":"Ma","year":"2019","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neubiorev.2026.106932_bib73","doi-asserted-by":"crossref","unstructured":"Magagnoli, J., Yerramothu, P., Ambati, K., Cummings, T., Nguyen, J., Thomas, C.C., Wang, S.-b, Cheng, K., Juraev, M., Dholkawala, R., Nagasaka, A., Ambati, M., Nagasaka, Y., Ban, A., Ambati, V.L., Sutton, S.S., Gelfand, B.D., & Ambati, J. (2023). Reduction of human Alzheimer\u2019s disease risk and reversal of mouse model cognitive deficit with nucleoside analog use. In.","DOI":"10.1101\/2023.03.17.23287375"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106932_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70180","article-title":"Association of nucleoside reverse transcriptase inhibitor use with reduced risk of Alzheimer's disease risk","volume":"21","author":"Magagnoli","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106932_bib75","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/GME.0000000000001725","article-title":"Cognitive changes during the menopausal transition: a longitudinal study in women with and without HIV","volume":"28","author":"Maki","year":"2021","journal-title":"Menopause"},{"issue":"24","key":"10.1016\/j.neubiorev.2026.106932_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417146","article-title":"Astrocyte involvement in blood-brain barrier function: a critical update highlighting novel, complex, neurovascular interactions","volume":"24","author":"Manu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106932_bib77","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-1-4939-9072-6_18","article-title":"Human glial chimeric mice to define the role of glial pathology in human disease","volume":"1936","author":"Mariani","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neubiorev.2026.106932_bib78","article-title":"HIV infection in microglia leads to senescence, triggering activation of neurotoxicity pathways","author":"Mason","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.neubiorev.2026.106932_bib79","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.neuropharm.2017.06.026","article-title":"Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease","volume":"123","author":"Mast","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib80","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13024-019-0311-y","article-title":"Human Interleukin-34 facilitates microglia-like cell differentiation and persistent HIV-1 infection in humanized mice","volume":"14","author":"Mathews","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2026.106932_bib81","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.neubiorev.2021.04.035","article-title":"Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disorders","volume":"127","author":"Michetti","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106932_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119605","article-title":"The S100B protein: a multifaceted pathogenic factor more than a biomarker","volume":"24","author":"Michetti","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.neubiorev.2026.106932_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13154542","article-title":"CSF neopterin levels are elevated in various neurological diseases and aging","volume":"13","author":"Miyaue","year":"2024","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib84","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12974-016-0613-8","article-title":"Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicity","volume":"13","author":"Moidunny","year":"2016","journal-title":"J. Neuroinflamm."},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106932_bib85","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3390\/pathogens10081018","article-title":"Advances in SIV\/SHIV non-human primate models of NeuroAIDS","volume":"10","author":"Moretti","year":"2021","journal-title":"Pathogens"},{"issue":"22","key":"10.1016\/j.neubiorev.2026.106932_bib86","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1097\/CM9.0000000000002480","article-title":"Association of apolipoprotein E epsilon 4 and cognitive impairment in adults living with human immunodeficiency virus: a meta-analysis","volume":"135","author":"Mu","year":"2022","journal-title":"Chin. Med. J. (Engl. )"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib87","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40478-022-01375-y","article-title":"Frontal lobe microglia, neurodegenerative protein accumulation, and cognitive function in people with HIV","volume":"10","author":"Murray","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"issue":"20","key":"10.1016\/j.neubiorev.2026.106932_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252011170","article-title":"HIV-associated neurocognitive disorder (HAND) and Alzheimer's disease pathogenesis: future directions for diagnosis and treatment","volume":"25","author":"Mustafa","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106932_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.gendis.2025.101576","article-title":"New genetic insights into HIV-associated neurocognitive disorder and Alzheimer's disease","author":"Nguyen","year":"2025","journal-title":"Genes. & Dis."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106932_bib90","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s13760-017-0816-5","article-title":"Alzheimer\u2019s disease CSF biomarkers: clinical indications and rational use","volume":"117","author":"Niemantsverdriet","year":"2017","journal-title":"Acta Neurol. Belg."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106932_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/v17040467","article-title":"Microglia exhibit a unique intact HIV reservoir in human postmortem brain tissue","volume":"17","author":"Nuhn","year":"2025","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106932_bib92","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/0115672050313419240520051751","article-title":"Plasma biomarkers in neurodegenerative dementias: unrevealing the potential of serum oxytocin, BDNF, NPTX1, TREM2, TNF-alpha, IL-1 and prolactin","volume":"21","author":"Olgun","year":"2024","journal-title":"Curr. Alzheimer Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006112","article-title":"Early antiretroviral therapy is associated with lower HIV DNA molecular diversity and lower inflammation in cerebrospinal fluid but does not prevent the establishment of compartmentalized HIV DNA populations","volume":"13","author":"Oliveira","year":"2017","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.neubiorev.2026.106932_bib94","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2019.21","article-title":"Neprilysin as a biomarker: challenges and opportunities","volume":"6","author":"Pavo","year":"2020","journal-title":"Card. Fail. Rev."},{"issue":"5-6","key":"10.1016\/j.neubiorev.2026.106932_bib95","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0197-0186(01)00048-1","article-title":"Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease","volume":"39","author":"Peskind","year":"2001","journal-title":"Neurochem. Int."},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106932_bib96","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamaneurol.2025.1601","article-title":"White matter abnormalities and cognition in aging and Alzheimer disease","volume":"82","author":"Peter","year":"2025","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/cells13010054","article-title":"The role of TNF-alpha in Alzheimer's disease: a narrative review","volume":"13","author":"Plantone","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.neubiorev.2026.106932_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.788150","article-title":"Increased Serum NSE and S100B indicate neuronal and glial alterations in subjects under 71 years with mild neurocognitive disorder\/mild cognitive impairment","volume":"16","author":"Polyakova","year":"2022","journal-title":"Front. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106932_bib99","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s11481-013-9491-3","article-title":"Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection","volume":"8","author":"Price","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106932_bib100","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200095","article-title":"Levels of soluble interleukin 6 receptor and Asp358Ala are associated with cognitive performance and alzheimer disease biomarkers","volume":"10","author":"Quillen","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106932_bib101","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00002030-200501280-00004","article-title":"HIV-1 Tat inhibits neprilysin and elevates amyloid b","volume":"19","author":"Rempel","year":"2005","journal-title":"eta. AIDS (Lond. Engl. )"},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106932_bib102","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3390\/ijerph19042359","article-title":"Aging with HIV: increased risk of HIV comorbidities in older adults","volume":"19","author":"Roomaney","year":"2022","journal-title":"Int. J. Environ. Res. Public. Health"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106932_bib103","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jnnp-2018-319148","article-title":"Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies","volume":"90","author":"Shen","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106932_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000660","article-title":"HIV-1 Tat-mediated astrocytic amyloidosis involves the HIF-1\u03b1\/lncRNA BACE1-AS axis","volume":"18","author":"Sil","year":"2020","journal-title":"PLOS Biol."},{"key":"10.1016\/j.neubiorev.2026.106932_bib105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-444-63849-6.00003-7","article-title":"Neuropathogenesis of human immunodeficiency virus infection","volume":"152","author":"Sillman","year":"2018","journal-title":"Handb. Clin. Neurol."},{"issue":"14","key":"10.1016\/j.neubiorev.2026.106932_bib106","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1097\/QAD.0000000000001927","article-title":"Association of antiretroviral therapy with brain aging changes among HIV-infected adults","volume":"32","author":"Soontornniyomkij","year":"2018","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib107","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s44400-024-00001-z","article-title":"A Phase IIa clinical trial to evaluate the effects of anti-retroviral therapy in Alzheimer's disease (ART-AD)","volume":"1","author":"Sullivan","year":"2025","journal-title":"NPJ Dement."},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106932_bib108","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41593-018-0194-1","article-title":"Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies","volume":"21","author":"Sun","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106932_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/v15061319","article-title":"Alzheimer's disease pathology in middle aged and older people with HIV: comparisons with non-HIV controls on a healthy aging and Alzheimer's disease trajectory and relationships with cognitive function","volume":"15","author":"Sundermann","year":"2023","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106932_bib110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41423-024-01144-y","article-title":"gp120-derived amyloidogenic peptides form amyloid fibrils that increase HIV-1 infectivity","volume":"21","author":"Tan","year":"2024","journal-title":"Cell. Mol. Immunol."},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106932_bib111","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167417","article-title":"Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy","volume":"133","author":"Tang","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neubiorev.2026.106932_bib112","series-title":"Handbook of the Biology and Pathology of Mental Disorders","first-page":"1569","article-title":"HIV-Associated Neurocognitive Disorders and Cerebrospinal Fluid as a Biomarker Platform","author":"Thela","year":"2025"},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106932_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/v14040753","article-title":"Patterns of cerebrospinal fluid Alzheimer's dementia biomarkers in people living with HIV: cross-sectional study on associated factors according to viral control, neurological confounders and neurocognition","volume":"14","author":"Trunfio","year":"2022","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106932_bib114","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/QAD.0000000000003880","article-title":"Plasma neurofilament light chain protein predicts greater brain-age gap, cognition, and cardiovascular risk in people with HIV","volume":"38","author":"Vance","year":"2024","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106932_bib115","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00415-023-12066-6","article-title":"Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study","volume":"271","author":"Vrillon","year":"2024","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12977-023-00616-9","article-title":"HIV infection of non-classical cells in the brain","volume":"20","author":"Wahl","year":"2023","journal-title":"Retrovirology"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106932_bib117","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13798","article-title":"The reverse transcriptase inhibitor 3TC protects against age-related cognitive dysfunction","volume":"22","author":"Wahl","year":"2023","journal-title":"Aging Cell."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106932_bib118","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/JLB.5VMR0322-161R","article-title":"Animal models for studies of HIV-1 brain reservoirs","volume":"112","author":"Waight","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.neubiorev.2026.106932_bib119","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fcimb.2019.00362","article-title":"Microglial cells: the main HIV-1 reservoir in the brain","volume":"9","author":"Wallet","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106932_bib120","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s10787-025-02092-3","article-title":"NLRP3 inflammasome and Alzheimer's disease: bridging inflammation and neurodegeneration","volume":"34","author":"Wasim","year":"2026","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106932_bib121","first-page":"23","article-title":"Use of humanized mouse models for studying HIV-1 infection, pathogenesis and persistence","volume":"2","author":"Weichseldorfer","year":"2020","journal-title":"J. AIDS HIV Treat."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106932_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70084","article-title":"Amyloid precursor protein and presenilin-1 knock-in immunodeficient mice exhibit intraneuronal Abeta pathology, microgliosis, and extensive neuronal loss","volume":"21","author":"Yeapuri","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106932_bib123","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14737159.2017.1341313","article-title":"Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls","volume":"17","author":"Yilmaz","year":"2017","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106932_bib124","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/QAI.0000000000003184","article-title":"Dementias among older males and females in the U.S. medicare system with and without HIV","volume":"93","author":"Yu","year":"2023","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106932_bib125","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s11481-011-9259-6","article-title":"HIV-1 gp120-induced axonal injury detected by accumulation of beta-amyloid precursor protein in adult rat corpus callosum","volume":"6","author":"Zhang","year":"2011","journal-title":"J. Neuroimmune Pharmacol."}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763426003891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763426003891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:37:40Z","timestamp":1790257060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763426003891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":125,"alternative-id":["S0149763426003891"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.106932","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does HIV-1 infection drive Alzheimer\u2019s disease pathobiology?","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.106932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106932"}}